We accelerate the development of new medicines, so the pets we love can lead happier and healthier lives.
Proven Leaders
We've built startups, climbed the ladder in Fortune 100, and everything in between
Solving Unmet Needs
We focus exclusively on solving the unmet needs of the animal health community
Advanced Technology
We use software end-to-end to accelerate drug development
Investors
Bookmark our new investor relations section to see timely business updates and the latest accounting reports from our CFO.
Anivive is led by a seasoned mix of entrepreneurs, pet industry executives, and software innovators.
85+ FDA
approvals (CVM NADA)
1,200+
animal studies overseen
650+
peer reviewed publications
$1B+
annual direct-to-vet sales
Lynne Doti PhD
Robert Bishop PhD
David Bruyette DVM
Dylan Balsz
Glenn Stearns
Kevin McCarthy
James Beaubien
Scott Whitcup
Lynne Doti PhD